Mavacamtamex (Mavacor)
Product detail for Mavacamtamex, INN: mavacamtamex. Therapeutic area: Cardiovascular. This record shows all linked substances, markets, applications, presentations, and labeling artefacts.
Product ID
PROD-030
INN
mavacamtamex
Therapeutic Area
Cardiovascular
Status
Active
Owner
Sarah Chen
Created
2022-02-18
Last Updated
2023-07-24
Markets
11
Presentations
| Form | Strength | Route |
|---|---|---|
| Transdermal patch | 1 mg/mL | Intramuscular |
| Hard capsule | 2.5 mg | Topical |
Active Substances
| ID | Name | INN | CAS | Type | Status |
|---|---|---|---|---|---|
| SUB-017 | Thymosilib | thymosilib | 94484-27-2 | biologic | Active |
| SUB-033 | Polysorbate 80 | polysorbate 80 | 53322-74-8 | combination | Active |
Applications (3)
| Application # | Market | Procedure Type | Status | Owner | Submitted |
|---|---|---|---|---|---|
| MFDS-2020-0030 | Denmark | sMAA | Submitted | Nadia Petrova | 2022-12-03 |
| MOH-IL-2020-0060 | Denmark | Lifecycle Extension | Failed | Nadia Petrova | 2023-11-13 |
| MFDS-2020-0090 | Denmark | NDA | Overdue | Marcus Webb | 2022-07-04 |
Markets (11)